Kenrick Ng speaks to ecancer about advances and treatment strategies for metastatic hormone-sensitive prostate cancer.

Kenrick starts by giving some background on how changes to the landscape of treating metastatic hormone-sensitive prostate cancer have accelerated and what challenges this creates for clinicians.

He gives his insights on some of the treatment options available and advice on factors to consider when choosing between them.

Kenrick stresses the importance of consulting patients about potential benefits and side effects of different therapies, and concludes with his key advice for clinicians.